This seminar reviews the aetiology, clinical presentation, approach to diagnosis, and management of Immunocompetent adults with community-acquired pneumonia (CAP).
Pneumonia Is a common clinical entity, particularly among the elderly.
A thorough understanding of the epidemiology and microbiology of CAP Is essential for appropriate diagnosis and management.
Although the microbiology of CAP has remained relatively stable over the last decade, there Is new Information on the incldence of atypical pathogens, particularly In patients not admitted to hospital, and new information on the Incidence of pathogens In cases of severe CAP and In CAP In the elderly.
Recent studies have provided new data on risk factors for mortality In CAP, which can assist the clinician In decisions about the need for hospital admission.
The emergence of antimicrobial resistance In Streptococcus pneumonlae, the organism responsible for most cases of CAP, has greatly affected the approach to therapy, especially In those patients who are treated empirically.
Guidelines for the therapy of CAP have been published by the Amerlcan Thoracic Soclety, the British Thoracic Soclety, and, most recently, the infectious Diseases Society of Amerlca.
These guidelines differ In their emphasis on emplrical versus pathogenic-specific management.
Mots-clés Pascal : Pneumopathie, Infection communautaire, Epidémiologie, Etiopathogénie, Exploration clinique, Diagnostic, Antibiotique, Chimiothérapie, Facteur risque, Prévention, Article synthèse, Homme, Appareil respiratoire pathologie, Poumon pathologie
Mots-clés Pascal anglais : Pneumopathy, Community acquired infection, Epidemiology, Etiopathogenesis, Clinical investigation, Diagnosis, Antibiotic, Chemotherapy, Risk factor, Prevention, Review, Human, Respiratory disease, Lung disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0490424
Code Inist : 002B05B02E. Création : 19/02/1999.